Skip to main content
Figure 1 | Radiation Oncology

Figure 1

From: Trimodality bladder-sparing approach without neoadjuvant chemotherapy for node-negative localized muscle-invasive urinary bladder cancer resulted in comparable cystectomy-free survival

Figure 1

Overall survival of all patients and comparison between CR and non-CR patients. (A) The median survival, 2-year and 5-year OS rate of all patients were 64.6 months (95% CI, 32.3 to 97.0 months), 65.7% (95% CI, 52.6% to 76.0%), 50.8%. (95% CI, 36.7% to 63.2%). (B) Two-year overall survival rate was statistically higher among those with complete response than those without (79.4% [95% CI, 67.2% to 91.6%] vs. 33.3% [95% CI, 7.6% to 59.9%]; p < 0.001).

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us